CTRI/2024/01/061952尚未招募4 期
Comparative study of albuminuria lowering effect of dapagliflozin and dapagliflozin plus eplerenone in patients with Diabetes mellitus: A parallel group, unblinded randomized controlled trial.
Dr Nikhil Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •b)Patients having urinary albumin to creatinine ratio (UACR) more than >30mg/mmol.
排除标准
- •a)Failure to give consent
- •b)History of serious reactions to dapagliflozin and eplerenone
- •c)Severe renal impairment (eGfr less than 30/ml/min/1.73m2
- •d)End-stage renal disease (ESRD)
- •e)Patient on dialysis
- •f)Patient having serum potassium >5.5meq/l at initiation
- •g)Concomitant administration of strong cyp3a inhibitors (e.g. ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir and nelfinavir
- •h)Concomitant administration of potassium supplements or potassium-sparing diuretics
研究者
相似试验
进行中（未招募）
不适用
A study to examine whether the glucose lowering medicine dapagliflozin decreases urinary protein excretion and to determine the variation in response to dapagliflozin in plasma glucose / urinary protein excretion / blood pressure between and within patients.Patients with type 2 diabetes and albuminuria between 100 and 3500 mg/g.EUCTR2014-000157-37-NLniversity Medical Center Groningen
已完成
4 期
A study to assess the anti-albuminuric effects and variability in response to dapagliflozin in subjects with type 2 diabetesAlbuminuria in patients with type 2 diabetes1001265310029149NL-OMON40930niversitair Medisch Centrum Groningen36
已完成
4 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetesAlbuminuria in patients with diabetes10029149NL-OMON47659niversitair Medisch Centrum Groningen22
尚未招募
不适用
IMPROVEType 2 diabetesHigh AlbuminuriaNL-OMON23733niversity Medical Center Groningen36
招募中
2 期
The effect of albumin administration on mortality rate, lung involvement rate and blood oxygen in patients with covid-19 hospitalized in the intensive care unitIRCT20221011056144N1Karaj University of Medical Sciences52